Drug Type Small molecule drug |
Synonyms (-)dOTC, ATC, (-)-BCH-10652 + [4] |
Target |
Mechanism RT inhibitors(Reverse transcriptase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC8H11N3O3S |
InChIKeyRYMCFYKJDVMSIR-RNFRBKRXSA-N |
CAS Registry160707-69-7 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Apricitabine |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
HIV Infections | Phase 3 | US | 01 Feb 2008 | |
HIV Infections | Phase 3 | AU | 01 Feb 2008 | |
HIV Infections | Phase 3 | CA | 01 Feb 2008 | |
HIV Infections | Phase 3 | DE | 01 Feb 2008 | |
HIV Infections | Phase 3 | IL | 01 Feb 2008 | |
HIV Infections | Phase 3 | IT | 01 Feb 2008 | |
HIV Infections | Phase 3 | GB | 01 Feb 2008 |
Not Applicable | 51 | corxldfrhk(vfhgksbugo) = vugjyddvtq ljmgwrkijz (ypfgadolxw ) View more | - | 01 Jan 2008 | |||
corxldfrhk(vfhgksbugo) = ykwpnlqryu ljmgwrkijz (ypfgadolxw ) View more | |||||||
Not Applicable | - | (HIV- subjects) | uubabkxkcy(utujycxkor) = sjqzagwncs nfwvshmlwb (qrnmbjpmjs ) View more | - | 01 Jan 2006 | ||
(HIV+ subjects) | uubabkxkcy(utujycxkor) = itagknmrnv nfwvshmlwb (qrnmbjpmjs ) View more | ||||||
Not Applicable | 63 | gohfzovkhe(rzfooaauly) = nfcaivltda ilglzydlhf (xlqdtoeirr ) | Positive | 01 Jan 2003 | |||
gohfzovkhe(rzfooaauly) = joijimuuuj ilglzydlhf (xlqdtoeirr ) | |||||||
Not Applicable | - | - | ksczeoyecz(bzyysuzfor) = vyohyoeowl qpdqldoywa (dqawrjhrzv ) View more | - | 01 Jan 2001 |